Seelos Therapeutics, Inc.
SEELQ
$0.0005
$0.000.00%
OTC PK
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 105.80% | 80.17% | 70.77% | 153.55% | -38.66% |
| Total Depreciation and Amortization | 7.14% | 7.14% | -71.70% | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -120.40% | -143.57% | -188.85% | -791.44% | 960.41% |
| Change in Net Operating Assets | -67.19% | 117.87% | 38.15% | 10.19% | 508.54% |
| Cash from Operations | 83.54% | 55.14% | 85.40% | 48.09% | 71.05% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 92.00% | -2.18% | -14.09% | -- | -- |
| Issuance of Common Stock | -- | -69.32% | -- | 810.40% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 132.09% | -75.55% | 223.04% | 645.51% | -1,734.92% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 97.20% | -67.71% | 102.75% | 69.66% | 59.96% |